These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 26259026

  • 1. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A.
    Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026
    [Abstract] [Full Text] [Related]

  • 2. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M, Rau M, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Lammert F, Geier A, NAFLD Clinical Study Group.
    J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
    [Abstract] [Full Text] [Related]

  • 3. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.
    Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075
    [Abstract] [Full Text] [Related]

  • 4. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM.
    BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449
    [Abstract] [Full Text] [Related]

  • 5. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.
    Petta S, Grimaudo S, Cammà C, Cabibi D, Di Marco V, Licata G, Pipitone RM, Craxì A.
    J Hepatol; 2012 Jun 19; 56(6):1356-62. PubMed ID: 22314430
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
    Kang Q, Xu J, Luo H, Tan N, Chen H, Cheng R, Pan J, Han Y, Yang Y, Liu D, Xi H, Yu M, Xu X.
    Gene; 2022 Apr 30; 820():146235. PubMed ID: 35143946
    [Abstract] [Full Text] [Related]

  • 7. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
    Stättermayer AF, Rutter K, Beinhardt S, Scherzer TM, Stadlmayr A, Hofer H, Wrba F, Steindl-Munda P, Krebs M, Datz C, Trauner M, Ferenci P.
    J Hepatol; 2012 Sep 30; 57(3):492-8. PubMed ID: 22634340
    [Abstract] [Full Text] [Related]

  • 8. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
    Petta S, Vanni E, Bugianesi E, Rosso C, Cabibi D, Cammà C, Di Marco V, Eslam M, Grimaudo S, Macaluso FS, McLeod D, Pipitone RM, Abate ML, Smedile A, George J, Craxì A.
    Aliment Pharmacol Ther; 2015 May 30; 41(10):939-48. PubMed ID: 25801076
    [Abstract] [Full Text] [Related]

  • 9. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
    Coppola N, Rosa Z, Cirillo G, Stanzione M, Macera M, Boemio A, Grandone A, Pisaturo M, Marrone A, Adinolfi LE, Sagnelli E, Miraglia del Giudice E.
    Liver Int; 2015 Aug 30; 35(8):1959-63. PubMed ID: 25581573
    [Abstract] [Full Text] [Related]

  • 10. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    Koo BK, Joo SK, Kim D, Bae JM, Park JH, Kim JH, Kim W.
    J Gastroenterol Hepatol; 2018 Jun 30; 33(6):1277-1285. PubMed ID: 29193269
    [Abstract] [Full Text] [Related]

  • 11. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
    Oliveira AIN, Malta FM, Zitelli PMY, Salles APM, Gomes-Gouvea MS, Nastri ACS, Pinho JRR, Carrilho FJ, Oliveira CP, Mendes-Corrêa MC, Pessoa MG, Mazo DF.
    BMC Gastroenterol; 2021 Feb 23; 21(1):81. PubMed ID: 33622266
    [Abstract] [Full Text] [Related]

  • 12. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.
    PLoS One; 2015 Feb 23; 10(11):e0143429. PubMed ID: 26599080
    [Abstract] [Full Text] [Related]

  • 13. Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population.
    Elmansoury N, Megahed AA, Kamal A, El-Nikhely N, Labane M, Abdelmageed M, Daly AK, Wahid A.
    Genes (Basel); 2024 Apr 04; 15(4):. PubMed ID: 38674389
    [Abstract] [Full Text] [Related]

  • 14. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    Yasui K, Kawaguchi T, Shima T, Mitsuyoshi H, Seki K, Sendo R, Mizuno M, Itoh Y, Matsuda F, Okanoue T.
    J Gastroenterol; 2015 Aug 04; 50(8):887-93. PubMed ID: 25543233
    [Abstract] [Full Text] [Related]

  • 15. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.
    Míková I, Neřoldová M, Hubáček JA, Dlouhá D, Jirsa M, Honsová E, Sticová E, Lánská V, Špičák J, Trunečka P.
    Transplantation; 2020 Mar 04; 104(3):526-534. PubMed ID: 31356578
    [Abstract] [Full Text] [Related]

  • 16. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.
    Ampuero J, Del Campo JA, Rojas L, García-Lozano JR, Solá R, Andrade R, Pons JA, Navarro JM, Calleja JL, Buti M, González-Escribano MF, Forns X, Diago M, García-Samaniego J, Romero-Gómez M.
    Ann Hepatol; 2014 Mar 04; 13(4):356-63. PubMed ID: 24927606
    [Abstract] [Full Text] [Related]

  • 17. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.
    Falleti E, Cussigh A, Cmet S, Fabris C, Toniutto P.
    Dig Liver Dis; 2016 Jan 04; 48(1):69-75. PubMed ID: 26493626
    [Abstract] [Full Text] [Related]

  • 18. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
    Clark PJ, Thompson AJ, Zhu Q, Vock DM, Zhu M, Patel K, Harrison SA, Naggie S, Ge D, Tillmann HL, Urban TJ, Shianna K, Fellay J, Goodman Z, Noviello S, Pedicone LD, Afdhal N, Sulkowski M, Albrecht JK, Goldstein DB, McHutchison JG, Muir AJ.
    Dig Dis Sci; 2012 Aug 04; 57(8):2213-21. PubMed ID: 22543885
    [Abstract] [Full Text] [Related]

  • 19. [Correlation between PNPLA3 rs738409 and TM6SF2 rs58542926 gene polymorphism and primary liver cancer in the Han Population of China's Northeast region].
    Bing H, Wang W, Li YL.
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb 20; 29(2):156-162. PubMed ID: 33685085
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive characterization of graft steatosis after liver transplantation.
    Karlas T, Kollmeier J, Böhm S, Müller J, Kovacs P, Tröltzsch M, Weimann A, Bartels M, Rosendahl J, Mössner J, Berg T, Keim V, Wiegand J.
    Scand J Gastroenterol; 2015 Feb 20; 50(2):224-32. PubMed ID: 25429378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.